Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
CRVO
$2.64
+2.72%
CRVO
· CervoMed Inc.
$2.64
+0.07 (+2.72%)
At close · Sep 2
Going-concern doubt
— cleared Aug 7, 2026
The latest filing no longer states the doubt (first flagged May 15, 2026).
View the 10-Q filed Aug 7, 2026Market Cap
$39.76M
Shares
15.12M
All earnings calls
Earnings call · FY2026 Q1
CervoMed Inc. (CRVO) Q1 2026 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$0
-100% YoY
Net income
-$7.96M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed May 18, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed May 15, 2026 · complete as-filed document